Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab

By Varo E.   Lopez A.   Castroagudin J.F.   Delgado M.   Conde R.   Ferrer E.   Otero E.   Tome S.   Bustamante M.   Rivero C.   Martinez J.   Marino A.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1533-1534

Elsevier

Access to resources Recommend Favorite

Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors

By Langer R.M.   Hong D.M.   Katz S.M.   Van Buren C.T.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3162-3164

Elsevier

Access to resources Recommend Favorite

Pediatric renal transplantation under tacrolimus or cyclosporine immunosuppression and basiliximab induction

By Garcia C.D.   Schneider L.   Barros V.R.   Guimaraes P.C.   Garcia V.D.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2533-2534

Elsevier

Access to resources Recommend Favorite

Enhanced efficacy of repeated anti-NCD8 monoclonal antibody therapy by high-dose cyclosporine treatment

By Allan J.S.   Slisz J.K.   Vesga L.   Arn J.S.   Yamada K.   Sachs D.H.   Madsen J.C.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4062-4063

Elsevier

Access to resources Recommend Favorite

Duration of action of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in pediatric kidney transplant recipients

By Sterkers G.   Baudouin V.   Ansart-Pirenne H.   Maisin A.   Niaudet P.   Cochat P.   Loirat C.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2757-2759

Elsevier

Access to resources Recommend Favorite